Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
The aim of this guideline is to provide an update on evidence-based recommendations for treatment of adult patients with PsA. The previous BSR guidelines for PsA were published in 2012 and since that time, there have been many new advanced therapies licensed for PsA. This update will provide practic...
Main Authors: | Tillett, W, Allen, A, Tucker, L, Chandler, D, Ciurtin, C, Davis, C, Dick, A, Foulkes, A, Gullick, N, Helliwell, P, Jadon, D, Jones, G, Kyle, S, Madhok, V, McHugh, N, Parkinson, A, Raine, T, Siebert, S, Smith, C, Coates, LC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2020
|
Similar Items
-
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
by: Tucker, L, et al.
Published: (2022) -
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
by: Watson, M, et al.
Published: (2024) -
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial
by: Watson, M, et al.
Published: (2024) -
Effect of concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) on the efficacy and safety of ixekizumab in biologic dmard-naive patients with active psoriatic arthritis
by: Coates, LC, et al.
Published: (2016) -
Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
by: Helliwell, PS, et al.
Published: (2021)